<< Back To Bloggers

Overview

Melanoma Research Alliance

The Melanoma Research Alliance commits strategic research funding to improve the understanding about the causes of melanoma and to develop better treatments for this deadly disease.

Articles

female scienitst analyzing a sample under a microscope while doing research

An Improved Clinical Trials Navigator for Melanoma Patients and Caregivers

Melanoma Research Alliance worked with Antidote to update its online tool to help people find clinical trials for this skin cancer.

The Future of Immunotherapy & Cell-based Therapies

Physician-scientist Antoni Ribas explores anti-PD-1 immunotherapy given before surgery, called neoadjuvant therapy.

Overcoming Melanoma and Finding Purpose: Brittanny Groover’s Story

After two surgeries to remove a cancerous mole and then immunotherapy for a year, Brittanny Groover advocates for melanoma prevention.

Toni English’s Journey from Mucosal Melanoma Patient to TIL Clinical Trial Participant and Advocate

In 2015 Toni saw a doctor because of frequent nosebleeds. She was diagnosed with a rare melanoma (cancer) and given six months to live.

Watch Videos From Melanoma Research Alliance’s 2024 Patient Forum

Melanoma patients gathered to provide lay-friendly, state-of-the-science education about skin cancer, scanxiety, clinical trials and more.

melanoma research alliance patient advocate

Improving Communication With Your Melanoma Care Team [VIDEO]

Watch experts offer tips, tricks and strategies to make sure patients and caregivers are proactive partners with their cancer care team.

Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma

Amtagvi is the first individualized tumor-infiltrating lymphocyte therapy to earn FDA approval for any cancer.

melanoma research alliance immunotherapy

Let’s Talk About Melanoma Immunotherapies and Immune-Related Adverse Events

A conversation with Dr. Alexandra-Chloé Villani about side effects melanoma patients may experience when receiving immunotherapy.

100,000 Americans Estimated to be Diagnosed with Invasive Melanoma in 2024

This report highlights the estimated number of new cases, prevalence, and survival statistics for cancer in the United States.

Hot topics

Breast Cancer

Lung Cancer

Liver Cancer

Prostate Cancer

Cancer Treatment

Cancer Screening

Ovarian Cancer

Blood Cancers - Leukemia/Lymphoma/Multiple Myeloma

Medical Science Laboratory: Portrait of Beautiful Black Scientist Looking Under Microscope

Melanoma and Microbiota: Current Understanding and Future Directions

We all have trillions of microorganisms that live throughout our bodies.

Melanoma Clinical Trials to Watch: December 2023

Lack of awareness of and participation in clinical trials are the biggest obstacles to bringing new skin cancer therapies to market.

illustration woman yoga seated position meditation

Mindfulness During the Holidays: Tips for the Melanoma Community

In the bustling holiday season, finding peace can be a gift.

Perseverance Through Advanced Melanoma: Clay Hummer

When his skin cancer returned, Clay Hummer sought clinical trials for more options to treatment the melanoma.

AI, Artificial intelligence, automation and modern information technology concept on virtual screen

Artificial Intelligence and Imaging in Melanoma Care: An Update

Research is conﬁrming that artiﬁcial intelligence and machine learning algorithms may revolutionize the speed of melanoma diagnosis.

Top view of camouflaged military clothing, stethoscope, US flag and boots on wooden backgroun

Melanoma Risk in the Military Community [VIDEO]

Watch MRA CEO Dr. Marc Hurlbert and Army Veteran Andrew Smith discuss the risk of this skin cancer among the military and veterans.

A History of Sunburns and an Early Stage Melanoma Diagnosis: Jill Roth

Roughly nine out of ten skin cancers— including melanoma—are caused by unprotected exposure to UV rays.

Female dermatologist examining female patient's skin with dermascope, doctor is carefully looking for signs of skin cancer

For Melanoma, How Much Adjuvant Therapy—Treatment After Surgery—Is Best?

Adjuvant immunotherapy can help reduce the likelihood of the skin cancer returning, but is more better or is less more?

We Welcome the Expanded Approval of Opdivo for Those With Stage 2 Melanoma

Reducing the risk of this deadly skin cancer recurring after surgery is an important goal, notes the Melanoma Research Alliance.